Maurizio Chiriva Internati Ph.D.
Net Worth

Last updated:

What is Maurizio Chiriva Internati Ph.D. net worth?

The estimated net worth of Dr. Maurizio Chiriva Internati Ph.D. is at least $1,863,224 as of 9 Sep 2021. He owns shares worth $111,624 as insider and has received compensation worth at least $1,751,600 in Kiromic BioPharma, Inc..

What is the salary of Maurizio Chiriva Internati Ph.D.?

Dr. Maurizio Chiriva Internati Ph.D. salary is $437,900 per year as Founder, Chairman, Chief Executive Officer & Pres in Kiromic BioPharma, Inc..

How old is Maurizio Chiriva Internati Ph.D.?

Dr. Maurizio Chiriva Internati Ph.D. is 57 years old, born in 1968.

What stocks does Maurizio Chiriva Internati Ph.D. currently own?

As insider, Dr. Maurizio Chiriva Internati Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Kiromic BioPharma, Inc. (KRBP) Founder, Chairman, Chief Executive Officer & Pres 1,378,072 $0.08 $111,624

What does Kiromic BioPharma, Inc. do?

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

Maurizio Chiriva Internati Ph.D. insider trading

Kiromic BioPharma, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 2,800 $3.7 $10,357

Kiromic BioPharma key executives

Kiromic BioPharma, Inc. executives and other stock owners filed with the SEC: